Reduced 11β-hydroxysteroid dehydrogenase type 1 activity in obese boys

European Journal of Endocrinology

Volumn 157, Issue 3, 2007, Pages 319-324

  Wiegand, Susanna ^a   Richardt, Anna ^a   Remer, Thomas ^b   Wudy, Stefan A ^c   Tomlinson, Jeremy W ^d   Hughes, Beverly ^d   Grüter, Annette ^a   Stewart, Paul M ^d   Strasburger, Christian J ^a   Quinkler, Marcus ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b RESEARCH INSTITUTE OF CHILD NUTRITION   (Germany)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CORTISONE; GLUCOCORTICOID; HYDROCORTISONE; TETRAHYDROCORTISOL; TETRAHYDROCORTISONE;

ADOLESCENT; ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; BOY; CHILDHOOD DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; CUSHING SYNDROME; ENZYME ACTIVITY; GAS CHROMATOGRAPHY; GLUCOSE HOMEOSTASIS; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INCIDENCE; INSULIN RESISTANCE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PUBERTY; SCHOOL CHILD; SCORING SYSTEM; STEROID EXCRETION; WAIST HIP RATIO; AGE; BIOSYNTHESIS; CHILD; ENZYME ACTIVATION; FEMALE; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MASS FRAGMENTOGRAPHY; METABOLISM; MORPHOMETRICS; PHYSIOLOGY; URINE;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ADOLESCENT; AGE FACTORS; BODY WEIGHTS AND MEASURES; CHILD; CORTISONE; ENZYME ACTIVATION; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; OBESITY; PITUITARY-ADRENAL SYSTEM;

EID: 35349021437     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/EJE-07-0193     Document Type: Article

References (44)

1. Bjorntorp P. Obesity. Lancet 1997 350 423-426.
2. Bjorntorp P. The regulation of adipose tissue distribution in humans. International Journal of Obesity and Related Metabolic Disorders 1996 20 291-302.
3. Rebuffe-Scrive M, Krotkiewski M, Elfverson J & Bjorntorp P. Muscle and adipose tissue morphology and metabolism in Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism 1988 67 1122-1128.
4. Mayo-Smith W, Hayes CW, Biller BM, Klibanski A, Rosenthal H & Rosenthal DI. Body fat distribution measured with CT: correlations in healthy subjects, patients with anorexia nervosa, and patients with Cushing syndrome. Radiology 1989 170 515-518.
5. Migeon CJ, Green OC & Eckert JP. Study of the adrenocortical function in obesity. Metabolism 1963 12 718-739.
6. Strecten DH. Is hypothalamic-pituitary-adrenal hyperactivity important in the pathogenesis of excessive abdominal fat distribution? Journal of Clinical Endocrinology and Metabolism 1993 77 339-340.
7. Stewart PM. 11β-hydroxysteroid dehydrogenase: implications for clinical medicine. Clinical Endocrinology 1996 44 493-499.
8. Tomlinson JW, Walker EA, Bujalska IJ, Draper N, Lavery GG, Cooper MS, Hewison M & Stewart PM. 11β-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocrine Reviews 2004 25 831-866.
9. Kotelevtsev Y, Holmes MC, Burchell A, Houston PM, Schmoll D, Jamieson P, Best R, Brown R, Edwards CRW, Seckl JR & Mullins JJ. 11β-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress. PNAS 1997 94 14924-14929.
10. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR & Flier JS. A transgenic model of visceral obesity and the metabolic syndrome. Science 2001 294 2166-2170.
11. Remer T, Boye KR, Hartmann MF & Wudy SA. Urinary markers of adrenarche: reference values in healthy subjects, aged 3-18 years. Journal of Clinical Endocrinology and Metabolism 2005 90 2015-2021.
12. Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K, Savoye M, Rieger V, Taksali S, Barbetta G, Sherwin RS & Caprio S. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. New England Journal of Medicine 2002 346 802-810.
13. Cole TJ, Power C & Preece MA. Child obesity and body-mass index. Lancet 1999 353 1188.
14. Cole TJ, Bellizzi MC, Flegal KM & Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 2000 320 1240-1243.
15. Wang Y, Moss J & Thisted R. Predictors of body surface area. Journal of Clinical Anesthesia 1992 4 4-10.
16. Shackleton CH. Mass spectrometry in the diagnosis of steroid-related disorders and in hypertension research. Journal of Steroid Biochemistry and Molecular Biology 1993 45 127-140.
17. Remer T, Maser-Gluth C, Boye KR, Hartmann ME, Heinze E & Wudy SA. Exaggerated adrenarche and altered cortisol metabolism in Type 1 diabetic children. Steroids 2006 71 591-598.
18. Zumoff B, Fukushima DK & Hellman L. Intercomparison of four methods for measuring cortisol production. Journal of Clinical Endocrinology and Metabolism 1974 38 169-175.
19. Andrew R, Phillips DI & Walker BR. Obesity and gender influence cortisol secretion and metabolism in man. Journal of Clinical Endocrinology and Metabolism 1998 83 1806-1809.
20. Ulick S, Tedde R & Wang JZ. Defective ring A reduction of cortisol as the major metabolic error in the syndrome of apparent mineralocorticoid excess. Journal of Clinical Endocrinology and Metabolism 1992 74 593-599.
21. Troiano RP & Flegal KM. Overweight children and adolescents: description, epidemiology, and demographics. Pediatrics 1998 101 497-504.
22. Wiegand S, Maikowski U, Blankenstein O, Biebermann H, Tarnow P & Gruters A. Type 2 diabetes and impaired glucose tolerance in European children and adolescents with obesity - a problem that is no longer restricted to minority groups. European Journal of Endocrinology 2004 151 199-206.
23. Wabitsch M, Hauner H, Heinze E, Bockmann A, Benz R, Mayer H & Teller W. Body fat distribution and steroid hormone concentrations in obese adolescent girls before and after weight reduction. Journal of Clinical Endocrinology and Metabolism 1995 80 3469-3475.
24. Pasquali R, Cantobelli S, Casimirri F, Capelli M, Bortoluzzi L, Flamia R, Labate AM & Barbara L. The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution. Journal of Clinical Endocrinology and Metabolism 1993 77 341-346.
25. Longui CA, Giusti MM, Calliari LE, Katiki T, Kochi C & Monte O. Partial glucocorticoid resistance in obese children detected by very low dose dexamethasone suppression test. Journal of Pediatric Endocrinology and Metabolism 2003 16 1277-1282.
26. Knutsson U, Dahlgren J, Marcus C, Rosberg S, Bronnegard M, Stierna P & Bertsson-Wikland K. Circadian cortisol rhythms in healthy boys and girls: relationship with age, growth, body composition, and pubertal development. Journal of Clinical Endocrinology and Metabolism 1997 82 536-540.
27. Sudi K, Gallistl S, Weinhandl G, Payer C, Cartellieri M & Borkenstein MH. No relationship between leptin and cortisol in obese children and adolescents. Journal of Pediatric Endocrinology and Metabolism 2000 13 913-921.
28. Check DB, Graystone JE, Seamark RF, McIntosh JE, Phillipou G & Court JM. Urinary steroid metabolites and the overgrowth of lean and fat tissues in obese girls. American Journal of Clinical Nutrition 1981 34 1804-1810.
29. Juricskay Z & Molnar D. Steroid metabolism in obese children II. Steroid excretion of obese and normal weight children. Acta Paediatrica Hungarica 1988 29 395-403.
30. Bleicher M, Hogel J, Wudy S, Wabitsch M, Homoki J, Sorgo W & Heinze E. Insulin resistance (HOMA) in relation to plasma cortisol, IGF-I and IGFBP-3. A study in normal short-statured and GH-deficient children. Hormone Research 2002 58 229-232.
31. Reinehr T & Andler W. Cortisol and its relation to insulin resistance before and after weight loss in obese children. Hormone Research 2004 62 107-112.
32. Tiosano D, Eisentein I, Militianu D, Chrousos GP & Hochberg Z. 11β-hydroxysteroid dehydrogenase activity in hypothalamic obesity. Journal of Clinical Endocrinology and Metabolism 2003 88 379-384.
33. Westerbacka J, Yki-Jarvinen H, Vehkavaara S, Hakkinen AM, Andrew R, Wake DJ, Seckl JR & Walker BR. Body fat distribution and cortisol metabolism in healthy men: enhanced 5β-reductase and lower cortisol /cortisone metabolite ratios in men with fatty liver. Journal of Clinical Endocrinology and Metabolism 2003 88 4924-4931.
34. Tomlinson JW, Sinha B, Bujalska I, Hewison M & Stewart PM. Expression of 11β-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity. Journal of Clinical Endocrinology and Metabolism 2002 87 5630-5635.
35. Dimitriou T, Maser-Gluth C & Remer T. Adrenocortical activity in healthy children is associated with fat mass. American Journal of Clinical Nutrition 2003 77 731-736.
36. Quinkler M, Sinha B, Tomlinson JW, Bujalska IJ, Stewart PM & Arlt W. Androgen generation in adipose tissue in women with simple obesity-a site-specific role for 17β-hydroxysteroid dehydrogenase type 5. Journal of Endocrinology 2004 183 331-342.
37. Stewart PM, Boulton A, Kumar S, Clark PMS & Shackleton CHL. Cortisol metabolism in human obesity: impaired cortisone to cortisol conversion in subjects with central adiposity. Journal of Clinical Endocrinology and Metabolism 1999 84 1022-1027.
38. Rask E, Olsson T, Söderberg S, Andrew R, Livingstone DE, Johnson O & Walker BR. Tissue-specific dysregulation of cortisol metabolism in human obesity. Journal of Clinical Endocrinology and Metabolism 2001 86 1418-1421.
39. Rask E, Walker BR, Soderberg S, Livingstone DE, Eliasson M, Johnson O, Andrew R & Olsson T. Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11β-hydroxysteroid dehydrogenase type 1 activity. Journal of Clinical Endocrinology and Metabolism 2002 87 3330-3336,
40. Reynolds RM, Walker BR, Syddall HE, Andrew R, Wood PJ, Whorwood CB & Phillips DI. Altered control of cortisol secretion in adult men with low birth weight and cardiovascular risk factors. Journal of Clinical Endocrinology and Metabolism 2001 86 245-250.
41. Andrew R, Gale CR, Walker BR, Seckl JR & Martyn CN. Glucocorticoid metabolism and the metabolic syndrome: associations in an elderly cohort. Experimental and Clinical Endocrinology & Diabetes 2002 110 284-290.
42. Fraser R, Ingram MC, Anderson NH, Morrison C, Davies E & Connell JM. Cortisol effects on body mass, blood pressure, and cholesterol in the general population. Hypertension 1999 33 1364-1368.
43. Csabi GY, Juricskay S & Molnar D. Urinary cortisol to cortisone metabolites in hypertensive obese children. Journal of Endocrinological Investigation 2000 23 435-439.
44. Valsamakis G, Anwar A, Tomlinson JW, Shackleton CH, McTernan PG, Chetty R, Wood PJ, Banerjee AK, Holder G, Barnett AH, Stewart PM & Kumar S. 11β-hydroxysteroid dehydrogenase type 1 activity in lean and obese males with type 2 diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 2004 89 4755-4761.